Lipocine Inc.
LPCN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001535955
No open-market purchases or sales by Lipocine Inc. insiders were filed in the last 90 days; 36 institutions reported holding it in 13F filings for Q2 2026, worth $7.63M in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding Lipocine Inc. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 18 | 22 | +4 |
| Shares | 528.5K | 529.3K | +852 (+0.2%) |
| Value | $1.67M | $1.51M | −$157.7K (−9.4%) |
New holders (4)
Institutions that held Lipocine Inc. at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citadel Advisors LLC | 14,247 | $40.7K | 0.00% |
| FMR LLC | 59 | $169 | 0.00% |
| Citigroup Inc | 3 | $9 | 0.00% |
| Royal Bank of Canada | 1 | $0 | 0.00% |
Sold out (0)
Institutions that held Lipocine Inc. at the end of Q2 2025 and filed for Q3 2025 without it.
None.